全文获取类型
收费全文 | 21854篇 |
免费 | 1430篇 |
国内免费 | 654篇 |
专业分类
耳鼻咽喉 | 566篇 |
儿科学 | 275篇 |
妇产科学 | 184篇 |
基础医学 | 4169篇 |
口腔科学 | 480篇 |
临床医学 | 1921篇 |
内科学 | 2361篇 |
皮肤病学 | 285篇 |
神经病学 | 3395篇 |
特种医学 | 694篇 |
外科学 | 1272篇 |
综合类 | 2320篇 |
预防医学 | 1412篇 |
眼科学 | 735篇 |
药学 | 2554篇 |
5篇 | |
中国医学 | 821篇 |
肿瘤学 | 489篇 |
出版年
2023年 | 217篇 |
2022年 | 326篇 |
2021年 | 773篇 |
2020年 | 630篇 |
2019年 | 578篇 |
2018年 | 584篇 |
2017年 | 599篇 |
2016年 | 563篇 |
2015年 | 607篇 |
2014年 | 1030篇 |
2013年 | 1345篇 |
2012年 | 1058篇 |
2011年 | 1181篇 |
2010年 | 1026篇 |
2009年 | 923篇 |
2008年 | 1006篇 |
2007年 | 997篇 |
2006年 | 912篇 |
2005年 | 766篇 |
2004年 | 744篇 |
2003年 | 626篇 |
2002年 | 570篇 |
2001年 | 492篇 |
2000年 | 482篇 |
1999年 | 401篇 |
1998年 | 404篇 |
1997年 | 379篇 |
1996年 | 358篇 |
1995年 | 347篇 |
1994年 | 275篇 |
1993年 | 270篇 |
1992年 | 290篇 |
1991年 | 273篇 |
1990年 | 223篇 |
1989年 | 205篇 |
1988年 | 214篇 |
1987年 | 200篇 |
1986年 | 183篇 |
1985年 | 298篇 |
1984年 | 239篇 |
1983年 | 186篇 |
1982年 | 199篇 |
1981年 | 189篇 |
1980年 | 156篇 |
1979年 | 165篇 |
1978年 | 107篇 |
1977年 | 87篇 |
1976年 | 88篇 |
1975年 | 34篇 |
1973年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
通过考察阿萨伊油、醇提物和水提物等拆分组分对虚热及虚寒证小鼠的温度趋向性动物行为学表征,环核苷酸及代谢水平等内在生化指标的影响,探讨阿萨伊各拆分组分的寒热药性特点以及寒凉的物质基础。将昆明种雄性小鼠随机分为空白组、虚热模型组、虚热+阿萨伊冻干原粉组、虚热+阿萨伊油组、虚热+阿萨伊醇提物组、虚热+阿萨伊水提物组、虚寒模型组、虚寒+肉桂组、虚寒+阿萨伊冻干原粉组、虚寒+阿萨伊油组、虚寒+阿萨伊醇提物组、虚寒+阿萨伊水提物组共12个组。虚热组小鼠每天下午灌胃给予甲状腺片溶液160 mg·kg-1,虚寒组小鼠给予氢化可的松溶液25 mg·kg-1,连续14 d,各给药组灌胃相关药物,实验结束后测定动物温度趋向性、环核苷酸及代谢水平等相关指标。阿萨伊醇提物同阿萨伊原粉一致,表现出对虚热模型小鼠的调整作用;阿萨伊油及其水提物同肉桂一致,表现出对虚寒模型小鼠的调整作用。该研究基于中药性味可拆分理论,采用同类比较异类反证的方法证明了阿萨伊醇提物性偏凉,油及其水提物性偏温的特征,并明确了醇提物为阿萨伊性凉的物质基础。 相似文献
32.
目的探讨低温等离子射频消融术联合顺铂注射液治疗喉癌的临床疗效及对患者血管内皮生长因子C(VEGF-C)和PTEN基因的影响。方法选取2017年1月至2018年8月间麻城市人民医院收治的150例喉癌患者,采用随机数表法分为观察组和对照组,每组75例。对照组患者采用喉镜下CO2激光切除术联合顺铂注射液治疗,观察组患者采用低温等离子射频消融术联合顺铂注射液治疗,比较两组患者的治疗效果、血清VEGF-C和PTEN及不良反应。结果观察组患者的临床疗效为72.0%,高于对照组患者的41.3%,差异有统计学意义(P<0.05)。治疗前,两组患者的血清VEGF-C和PTEN比较,差异无统计学意义(P>0.05)。治疗后,两组患者的血清VEGF-C和PTEN均下降,且观察组患者均低于对照组患者,差异均有统计学意义(均P<0.05)。观察组患者总生存时间及无瘤生存时间均高于对照组患者,差异均有统计学意义(均P<0.05)。两组患者的不良反应发生率比较,差异无统计学意义(P>0.05)。结论低温等离子射频消融术联合顺铂注射液治疗喉癌,可降低患者的VEGF-C和PTEN水平,治疗效果较好,建议临床推广。 相似文献
33.
《Fu? & Sprunggelenk》2022,20(4):239-249
IntroductionPediatric Lisfranc injuries are rare and a limited number of series or case reports have been published. Diagnosis can be easily missed and long-term outcome is not sufficiently presented. The primary aim of this paper is to review the literature about pediatric Lisfranc variants and equivalent injuries. This article also provides a review on Lisfranc joint anatomy, pediatric Lisfranc injuries, and stress or acute fractures involving the first and central (second to third) metatarsal (MT) bases, in an effort to detect potential pediatric Lisfranc variants and equivalent injuries, which were not accurately diagnosed.MethodsThe bibliographic survey to identify pediatric Lisfranc variants and equivalent injuries was conducted in the PubMed and Scopus databases, with no time limit. Four terms were used for searching in all possible combinations: Pediatric/children, Lisfranc/tarsometatarsal, variant/equivalent, injury/fracture. The only inclusion criterion was the age of the patients, which had to be less than 12 years. Reports on adolescents or adults were excluded.ResultsThe research indicated that there was only one study mentioning the pediatric Lisfranc equivalent injury, while there were no cases recorded as pediatric Lisfranc variants. The literature review regarding the final clinical outcome of both pediatric Lisfranc injuries and fractures, either stress or acute, involving the central MT base, indicated that early degenerative changes often occur, and may be responsible for chronic pain and activity limitation, even after mild and subtle low energy injuries.Discussion/ConclusionsThis review suggests that stress fractures involving the central MT base could be considered as a variant of the Lisfranc injury in children. Care should be taken to exclude occult fractures or ligamentous injuries to the medial and central Lisfranc joint complex in the presence of fractures involving the base or proximal portion of the first MT, including injuries to the physeal plate, to rule out the pediatric Lisfranc equivalent injury. 相似文献
34.
35.
《Clinical neurophysiology》2021,132(10):2639-2653
ObjectiveThis study brought together over 60 transcranial magnetic stimulation (TMS) researchers to create the largest known sample of individual participant single and paired-pulse TMS data to date, enabling a more comprehensive evaluation of factors driving response variability.MethodsAuthors of previously published studies were contacted and asked to share deidentified individual TMS data. Mixed-effects regression investigated a range of individual and study level variables for their contribution to variability in response to single and paired-pulse TMS data.Results687 healthy participant’s data were pooled across 35 studies. Target muscle, pulse waveform, neuronavigation use, and TMS machine significantly predicted an individual’s single-pulse TMS amplitude. Baseline motor evoked potential amplitude, motor cortex hemisphere, and motor threshold (MT) significantly predicted short-interval intracortical inhibition response. Baseline motor evoked potential amplitude, test stimulus intensity, interstimulus interval, and MT significantly predicted intracortical facilitation response. Age, hemisphere, and TMS machine significantly predicted MT.ConclusionsThis large-scale analysis has identified a number of factors influencing participants’ responses to single and paired-pulse TMS. We provide specific recommendations to minimise interindividual variability in single and paired-pulse TMS data.SignificanceThis study has used large-scale analyses to give clarity to factors driving variance in TMS data. We hope that this ongoing collaborative approach will increase standardisation of methods and thus the utility of single and paired-pulse TMS. 相似文献
36.
《Clinical neurophysiology》2021,132(11):2789-2797
ObjectiveThis study aims to discriminate the dynamic synchronization states from the subthalamic local field potentials and investigate their correlations with the motor symptoms in Parkinson’s Disease (PD).MethodsThe resting-state local field potentials of 10 patients with PD were recorded from the subthalamic nucleus. The dynamic neural states of multiple oscillations were discriminated and analyzed. The Spearman correlation was used to investigate the correlations between occurrence rate or duration of dynamic neural states and the severity of motor symptoms.ResultsThe proportion of long low-beta and theta synchronized state was significantly correlated with the general motor symptom and tremor, respectively. The duration of combined low/high-beta state was significantly correlated with rigidity, and the duration of combined alpha/high-beta state was significantly correlated with bradykinesia.ConclusionsThis study provides evidence that motor symptoms are associated with the neural states coded with multiple oscillations in PD.SignificanceThis study may advance the understanding of the neurophysiological mechanisms of the motor symptoms and provide potential biomarkers for closed-loop deep brain stimulation in PD. 相似文献
37.
目的 研究131I治疗分化型甲状腺癌(DTC)患者体内放射性活度及外部剂量水平的变化规律,分析二者之间的关系,并估算400 MBq患者剂量当量率的修正因子。方法 研究对象为43例甲状腺全切术后,首次行131I"清甲"治疗的DTC患者,服药量为1 850~3 700 MBq,平均服药量(2 405±777)MBq。分别于口服131I后2、6、20、22、24、27、30、44、46、48、54、68及72 h,测定患者的体内剩余放射性活度以及患者前部0.3、1及3 m处的剂量当量率。结果 患者服131I后的体内剩余放射性活度随时间变化函数为A=A0(1.033 16e-0.062 4t+0.017 17)。可估算出"清甲"治疗的DTC患者有效半减期为12.19 h,体内放射性活度降至400 MBq仅需26.4~38.9 h。患者服用131I后距其0.3、1及3 m的标准化剂量当量率随时间变化函数分别为:Ḣ0.3=127.220 7e-0.054 8t+3.765 71、Ḣ1=30.225 8e-0.064 4t+0.824 67、Ḣ3=4.161 9e-0.061 5t+0.167 97。患者服131I后体内剩余放射性活度与1 m处剂量当量率呈正相关(r=0.982,P<0.05),函数为Ḣ1=0.025A+1.245。DTC患者体内剩余活度分别为1 000、700和400 MBq时,距患者1 m处对应的剂量当量率分为26.2、18.7和11.2 μSv/h。估算活度为400 MBq的患者0.3、1及3 m处剂量当量率的修正因子分别为0.25、0.49及0.70。结论 服用131I活度在3 700 MBq以下的DTC患者仅需住院2日便可达到出院标准。当DTC患者体内活度降至400 MBq时,其1 m处的剂量当量率远小于25 μSv/h。单纯利用点源公式估算患者周围剂量当量率会造成高估的情况,因此对于公式估算患者周围辐射水平时使用的修正因子还需进一步研究,使模型估算结果更贴合实际情况。 相似文献
38.
Antonino Uncini Camillo Foresti Barbara Frigeni Benedetta Storti Maria Cristina Servalli Stefano Gazzina Giuseppe Cosentino Francesca Bianchi Ubaldo Del Carro Enrico Alfonsi Stefano Cotti Piccinelli Giovanni De Maria Alessandro Padovani Massimiliano Filosto Luigi Ippoliti 《Clinical neurophysiology》2021,51(2):183-191
39.
《Journal of vascular and interventional radiology : JVIR》2021,32(8):1103-1112.e12
PurposeTo investigate the feasibility, safety, and absorbed-dose distribution of prostatic artery radioembolization (RE) in a canine model.Materials and MethodsFourteen male castrated beagles received dihydroandrosterone/estradiol to induce prostatic hyperplasia for the duration of the study. Each dog underwent fluoroscopic prostatic artery catheterization. Yttrium-90 (90Y) microspheres (TheraSphere; Boston Scientific, Marlborough, Massachusetts) were delivered to 1 prostatic hemigland (dose escalation from 60 to 200 Gy), with the contralateral side serving as a control. Assessments for adverse events were performed throughout the follow-up (Common Terminology Criteria for Adverse Events v5.0). Positron emission tomography/magnetic resonance (MR) imaging provided a confirmation after the delivery of absorbed-dose distribution. MR imaging was performed before and 3, 20, and 40 days after RE. Tissue harvest of the prostate, rectum, bladder, urethra, penis, and neurovascular bundles was performed 60 days after RE.ResultsAll the animals successfully underwent RE. Positron emission tomography/MR imaging demonstrated localization to and good coverage of only the treated hemigland. No adverse events occurred. The MR imaging showed a significant dose-dependent decrease in the treated hemigland size at 40 days (25%–60%, P < .001). No extraprostatic radiographic changes were observed. Necropsy demonstrated no gross rectal, urethral, penile, or bladder changes. Histology revealed RE-induced changes in the treated prostatic tissues of the highest dose group, with gland atrophy and focal necrosis. No extraprostatic RE-related histologic findings were observed.ConclusionsProstate 90Y RE is safe and feasible in a canine model and leads to focal dose-dependent changes in the gland without inducing unwanted extraprostatic effects. These results suggest that an investigation of nonoperative prostate cancer is warranted. 相似文献
40.
Early axonal loss predicts long-term disability in chronic inflammatory demyelinating polyneuropathy
《Clinical neurophysiology》2021,132(4):1000-1007
ObjectiveTo investigate early pre-treatment nerve fiber loss as a predictor of long-term clinical outcome in chronic inflammatory demyelinating polyneuropathy (CIDP).MethodsIn 14 patients, motor and sensory conduction studies of the median, fibular, and sural nerves were performed at pre-treatment and follow-up 11–28 years later. Z-scores of amplitudes were combined as biomarkers of axonal loss and Z-scores of conduction properties as demyelination scores. The axonal loss was further examined by electromyography (EMG) and motor unit number estimation. Axonal and demyelination scores were compared to clinical outcomes in the Inflammatory Rasch-built Overall Disability Scale, the Neuropathy Impairment Score, and dynamometry.ResultsAt follow-up 12 patients walked independently, one needed support and one could not walk. The initial and follow-up axonal and demyelination scores were markedly abnormal. The initial axonal loss but not demyelination was strongly associated with both the follow-up axonal loss and the clinical measures. Moreover, delay of treatment initiation negatively influenced the axonal scores and clinical outcomes.ConclusionIn this hypothesis generating limited study, we found that axonal loss at early CIDP was highly predictive for long-term nerve fiber loss and disability.SignificanceThe study indicates that prompt initiation of treatment to prevent nerve fiber loss is necessary for outcome in CIDP. 相似文献